Payment overview · 2025
General Payments
$16.28
1 reported records · 1 companies
Healthcare provider profile · identity verified
Bryan F Porter, MD
Allopathic & Osteopathic Physicians|Family Medicine · NEWBERRY, IN · NPI 1689642357
Verified facts
What the public records show
CMS Open Payments records show Bryan F Porter, MD received $16.28 in general payments during 2025 across 1 reported records.
Biogen, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Biogen, Inc. | Unresolved — no canonical attribution shown | $16.28 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $16.28 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| ZURZUVAE Normalized: zurzuvae |
Drug | Biogen, Inc. | $16.28 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 502 | 127 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 412 | 88 |
| Lisinopril | Lisinopril | 383 | 100 |
| Levothyroxine Sodium | Levothyroxine Sodium | 380 | 80 |
| Omeprazole | Omeprazole | 375 | 91 |
| Amlodipine Besylate | Amlodipine Besylate | 374 | 95 |
| Gabapentin | Gabapentin | 344 | 72 |
| Furosemide | Furosemide | 276 | 57 |
| Eliquis | Apixaban | 266 | 43 |
| Escitalopram Oxalate | Escitalopram Oxalate | 259 | 48 |
| Metoprolol Succinate | Metoprolol Succinate | 252 | 60 |
| Tamsulosin Hcl | Tamsulosin Hcl | 232 | 49 |
| Potassium Chloride | Potassium Chloride | 217 | 45 |
| Montelukast Sodium | Montelukast Sodium | 209 | 51 |
| Pantoprazole Sodium | Pantoprazole Sodium | 192 | 45 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 182 | 64 |
| Losartan Potassium | Losartan Potassium | 181 | 51 |
| Sertraline Hcl | Sertraline Hcl | 181 | 28 |
| Hydrochlorothiazide | Hydrochlorothiazide | 180 | 51 |
| Carvedilol | Carvedilol | 169 | 38 |
| Fluticasone Propionate | Fluticasone Propionate | 168 | 63 |
| Metformin Hcl | Metformin Hcl | 168 | 47 |
| Duloxetine Hcl | Duloxetine Hcl | 167 | 30 |
| Lorazepam | Lorazepam | 165 | 37 |
| Alprazolam | Alprazolam | 163 | 37 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 154 | 42 |
| Metoprolol Tartrate | Metoprolol Tartrate | 149 | 39 |
| Famotidine | Famotidine | 148 | 29 |
| Allopurinol | Allopurinol | 142 | 34 |
| Nystatin | Nystatin | 139 | 40 |
| Spironolactone | Spironolactone | 138 | 31 |
| Prednisone | Prednisone | 136 | 56 |
| Memantine Hcl | Memantine Hcl | 132 | 27 |
| Simvastatin | Simvastatin | 130 | 31 |
| Clopidogrel | Clopidogrel Bisulfate | 124 | 25 |
| Tramadol Hcl | Tramadol Hcl | 119 | 35 |
| Trazodone Hcl | Trazodone Hcl | 119 | 28 |
| Meloxicam | Meloxicam | 114 | 27 |
| Pravastatin Sodium | Pravastatin Sodium | 108 | 30 |
| Donepezil Hcl | Donepezil Hcl | 106 | 21 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 97 | 22 |
| Ozempic | Semaglutide | 92 | 16 |
| Jardiance | Empagliflozin | 91 | 25 |
| Zolpidem Tartrate | Zolpidem Tartrate | 90 | 16 |
| Ondansetron Hcl | Ondansetron Hcl | 86 | 22 |
| Quetiapine Fumarate | Quetiapine Fumarate | 81 | 17 |
| Warfarin Sodium | Warfarin Sodium | 76 | 11 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 72 | 54 |
| Clonazepam | Clonazepam | 70 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 64 | 38 |
| Glimepiride | Glimepiride | 58 | 17 |
| Baclofen | Baclofen | 57 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 56 | 21 |
| Levetiracetam | Levetiracetam | 55 | suppressed |
| Xarelto | Rivaroxaban | 49 | 13 |
| Citalopram Hbr | Citalopram Hydrobromide | 48 | 11 |
| Ezetimibe | Ezetimibe | 48 | 14 |
| Buspirone Hcl | Buspirone Hcl | 47 | 14 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 47 | suppressed |
| Glipizide Er | Glipizide | 46 | 12 |
| Finasteride | Finasteride | 45 | suppressed |
| Atenolol | Atenolol | 44 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 44 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 44 | 11 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 43 | suppressed |
| Mirtazapine | Mirtazapine | 43 | suppressed |
| Synthroid | Levothyroxine Sodium | 43 | 13 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 42 | suppressed |
| Fluconazole | Fluconazole | 42 | 18 |
| Bumetanide | Bumetanide | 41 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 41 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 40 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 40 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 39 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 38 | 11 |
| Farxiga | Dapagliflozin Propanediol | 38 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 38 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 37 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 37 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 37 | 11 |
| Sucralfate | Sucralfate | 37 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 36 | 15 |
| Pregabalin | Pregabalin | 35 | suppressed |
| Digoxin | Digoxin | 34 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 34 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 33 | suppressed |
| Bupropion Xl | Bupropion Hcl | 33 | 11 |
| Dutasteride | Dutasteride | 33 | suppressed |
| Mounjaro | Tirzepatide | 33 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 32 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 32 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 31 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 31 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 30 | suppressed |
| Rybelsus | Semaglutide | 30 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 28 | suppressed |
| Azithromycin | Azithromycin | 28 | 23 |
| Fenofibrate | Fenofibrate Nanocrystallized | 28 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 28 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 28 | suppressed |
| Nitroglycerin | Nitroglycerin | 28 | 19 |
| Enalapril Maleate | Enalapril Maleate | 27 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 27 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 27 | suppressed |
| Glipizide | Glipizide | 26 | suppressed |
| Januvia | Sitagliptin Phosphate | 26 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 26 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 26 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 26 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 25 | suppressed |
| Topiramate | Topiramate | 25 | suppressed |
| Trulicity | Dulaglutide | 25 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 25 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 24 | 11 |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 24 | suppressed |
| Lamotrigine | Lamotrigine | 24 | suppressed |
| Rivastigmine | Rivastigmine | 24 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 24 | suppressed |
| Verapamil Er | Verapamil Hcl | 24 | suppressed |
| Folic Acid | Folic Acid | 23 | suppressed |
| Amoxicillin | Amoxicillin | 22 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 22 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 22 | suppressed |
| Trueplus Pen Needle | Pen Needle, Diabetic | 22 | suppressed |
| Aripiprazole | Aripiprazole | 21 | suppressed |
| Diazepam | Diazepam | 21 | suppressed |
| Mupirocin | Mupirocin | 21 | 19 |
| Phenobarbital | Phenobarbital | 21 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 20 | 11 |
| Fentanyl | Fentanyl | 20 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 20 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 20 | suppressed |
| Ondansetron Odt | Ondansetron | 19 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 19 | suppressed |
| Anastrozole | Anastrozole | 18 | suppressed |
| Caplyta | Lumateperone Tosylate | 18 | suppressed |
| Cephalexin | Cephalexin | 18 | 14 |
| Cyclosporine | Cyclosporine | 18 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 18 | suppressed |
| Metronidazole | Metronidazole | 18 | 15 |
| Morphine Sulfate | Morphine Sulfate | 18 | 11 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 18 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 18 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 17 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 17 | suppressed |
| Nyamyc | Nystatin | 17 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 17 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 17 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 16 | 16 |
| Ibuprofen | Ibuprofen | 16 | suppressed |
| Loperamide | Loperamide Hcl | 16 | suppressed |
| Ramipril | Ramipril | 16 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 16 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 16 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 15 | suppressed |
| Gemtesa | Vibegron | 15 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 15 | suppressed |
| Lansoprazole | Lansoprazole | 15 | suppressed |
| Methylphenidate Er | Methylphenidate Hcl | 15 | suppressed |
| Naproxen | Naproxen | 15 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 15 | suppressed |
| Novolog Flexpen | Insulin Aspart | 15 | suppressed |
| Valsartan | Valsartan | 15 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 15 | suppressed |
| Constulose | Lactulose | 14 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 14 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Lovastatin | Lovastatin | 14 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 14 | suppressed |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 14 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 14 | suppressed |
| Cefdinir | Cefdinir | 13 | 13 |
| Celecoxib | Celecoxib | 13 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 13 | suppressed |
| Lidocaine | Lidocaine | 13 | suppressed |
| Methocarbamol | Methocarbamol | 13 | suppressed |
| Novolin R | Insulin Regular, Human | 13 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 13 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 13 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 12 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 12 | suppressed |
| Cilostazol | Cilostazol | 12 | suppressed |
| Fenofibrate | Fenofibrate | 12 | suppressed |
| Nifedipine Er | Nifedipine | 12 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 12 | suppressed |
| Calcitriol | Calcitriol | 11 | suppressed |
| Creon | Lipase/Protease/Amylase | 11 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Ketoconazole | Ketoconazole | 11 | suppressed |
| Levofloxacin | Levofloxacin | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $16.28 · 1 records | Biogen, Inc. | ZURZUVAE | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error